UFP Technologies, Inc. (UFPT)
USD 187.03
(-3.41%)
USD 187.03
(-3.41%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 44.92 Million USD | 7.5% |
| 2022 | 41.78 Million USD | 163.06% |
| 2021 | 15.88 Million USD | 18.83% |
| 2020 | 13.36 Million USD | -32.31% |
| 2019 | 19.75 Million USD | 38.01% |
| 2018 | 14.31 Million USD | 55.39% |
| 2017 | 9.21 Million USD | 15.56% |
| 2016 | 7.97 Million USD | 4.97% |
| 2015 | 7.59 Million USD | 0.45% |
| 2014 | 7.55 Million USD | -32.96% |
| 2013 | 11.27 Million USD | 3.5% |
| 2012 | 10.89 Million USD | 5.3% |
| 2011 | 10.34 Million USD | 11.89% |
| 2010 | 9.24 Million USD | 55.96% |
| 2009 | 5.92 Million USD | 15.89% |
| 2008 | 5.11 Million USD | 23.01% |
| 2007 | 4.15 Million USD | 65.38% |
| 2006 | 2.51 Million USD | 281.57% |
| 2005 | 659.09 Thousand USD | -24.35% |
| 2004 | 871.26 Thousand USD | 157.48% |
| 2003 | -1.51 Million USD | -548.32% |
| 2002 | -233.79 Thousand USD | 92.32% |
| 2001 | -3.04 Million USD | -381.51% |
| 2000 | 1.08 Million USD | -36.41% |
| 1999 | 1.7 Million USD | 6.25% |
| 1998 | 1.6 Million USD | 23.08% |
| 1997 | 1.3 Million USD | 0.0% |
| 1996 | 1.3 Million USD | 44.44% |
| 1995 | 900 Thousand USD | 136.0% |
| 1994 | -2.5 Million USD | -1150.0% |
| 1993 | -200 Thousand USD | -200.0% |
| 1992 | 200 Thousand USD | 0.0% |
| 1991 | 200 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 16.36 Million USD | 20.73% |
| 2024 Q2 | 13.55 Million USD | 6.77% |
| 2024 Q1 | 12.69 Million USD | 9.35% |
| 2023 Q2 | 11.88 Million USD | 22.01% |
| 2023 Q1 | 9.73 Million USD | 15.09% |
| 2023 FY | 44.92 Million USD | 7.5% |
| 2023 Q3 | 11.69 Million USD | -1.59% |
| 2023 Q4 | 11.6 Million USD | -0.74% |
| 2022 FY | 41.78 Million USD | 163.06% |
| 2022 Q4 | 8.46 Million USD | -56.69% |
| 2022 Q3 | 19.54 Million USD | 118.84% |
| 2022 Q2 | 8.92 Million USD | 83.8% |
| 2022 Q1 | 4.85 Million USD | 50.92% |
| 2021 Q1 | 4.16 Million USD | -0.22% |
| 2021 Q4 | 3.21 Million USD | -15.04% |
| 2021 FY | 15.88 Million USD | 18.83% |
| 2021 Q3 | 3.78 Million USD | -19.64% |
| 2021 Q2 | 4.71 Million USD | 13.26% |
| 2020 FY | 13.36 Million USD | -32.31% |
| 2020 Q1 | 3.89 Million USD | -32.65% |
| 2020 Q2 | 2.31 Million USD | -40.43% |
| 2020 Q3 | 2.98 Million USD | 28.9% |
| 2020 Q4 | 4.17 Million USD | 39.63% |
| 2019 Q1 | 3.73 Million USD | -15.33% |
| 2019 Q2 | 4.59 Million USD | 23.14% |
| 2019 Q3 | 5.64 Million USD | 22.68% |
| 2019 Q4 | 5.77 Million USD | 2.41% |
| 2019 FY | 19.75 Million USD | 38.01% |
| 2018 Q4 | 4.41 Million USD | 6.68% |
| 2018 FY | 14.31 Million USD | 55.39% |
| 2018 Q3 | 4.13 Million USD | 3.61% |
| 2018 Q1 | 1.77 Million USD | -34.55% |
| 2018 Q2 | 3.99 Million USD | 124.54% |
| 2017 Q4 | 2.71 Million USD | 60.18% |
| 2017 FY | 9.21 Million USD | 15.56% |
| 2017 Q2 | 2.63 Million USD | 21.14% |
| 2017 Q1 | 2.17 Million USD | 45.61% |
| 2017 Q3 | 1.69 Million USD | -35.55% |
| 2016 Q1 | 1.07 Million USD | -35.86% |
| 2016 FY | 7.97 Million USD | 4.97% |
| 2016 Q3 | 2.66 Million USD | -2.41% |
| 2016 Q4 | 1.49 Million USD | -44.14% |
| 2016 Q2 | 2.73 Million USD | 154.42% |
| 2015 Q4 | 1.67 Million USD | -15.86% |
| 2015 FY | 7.59 Million USD | 0.45% |
| 2015 Q2 | 2.27 Million USD | 37.45% |
| 2015 Q1 | 1.65 Million USD | 5.22% |
| 2015 Q3 | 1.99 Million USD | -12.32% |
| 2014 Q4 | 1.57 Million USD | -23.96% |
| 2014 Q3 | 2.06 Million USD | 11.08% |
| 2014 Q2 | 1.86 Million USD | -9.8% |
| 2014 Q1 | 2.06 Million USD | -38.94% |
| 2014 FY | 7.55 Million USD | -32.96% |
| 2013 Q2 | 2.98 Million USD | 46.9% |
| 2013 FY | 11.27 Million USD | 3.5% |
| 2013 Q1 | 2.03 Million USD | -36.63% |
| 2013 Q3 | 2.88 Million USD | -3.19% |
| 2013 Q4 | 3.37 Million USD | 16.97% |
| 2012 Q1 | 2.34 Million USD | -21.82% |
| 2012 Q3 | 2.59 Million USD | -5.49% |
| 2012 Q4 | 3.2 Million USD | 23.38% |
| 2012 Q2 | 2.74 Million USD | 16.96% |
| 2012 FY | 10.89 Million USD | 5.3% |
| 2011 FY | 10.34 Million USD | 11.89% |
| 2011 Q4 | 3 Million USD | 23.37% |
| 2011 Q3 | 2.43 Million USD | -9.87% |
| 2011 Q2 | 2.7 Million USD | 22.54% |
| 2011 Q1 | 2.2 Million USD | -28.63% |
| 2010 FY | 9.24 Million USD | 55.96% |
| 2010 Q1 | 1.51 Million USD | -47.98% |
| 2010 Q2 | 2.28 Million USD | 50.96% |
| 2010 Q3 | 2.36 Million USD | 3.65% |
| 2010 Q4 | 3.08 Million USD | 30.63% |
| 2009 FY | 5.92 Million USD | 15.89% |
| 2009 Q2 | 566.19 Thousand USD | 64.13% |
| 2009 Q1 | 344.96 Thousand USD | -69.91% |
| 2009 Q4 | 2.9 Million USD | 37.52% |
| 2009 Q3 | 2.11 Million USD | 273.15% |
| 2008 FY | 5.11 Million USD | 23.01% |
| 2008 Q2 | 1.57 Million USD | 37.11% |
| 2008 Q1 | 1.14 Million USD | -35.4% |
| 2008 Q4 | 1.14 Million USD | -8.09% |
| 2008 Q3 | 1.24 Million USD | -20.77% |
| 2007 Q4 | 1.77 Million USD | 101.23% |
| 2007 FY | 4.15 Million USD | 65.38% |
| 2007 Q3 | 883.27 Thousand USD | -9.59% |
| 2007 Q2 | 976.96 Thousand USD | 87.37% |
| 2007 Q1 | 521.42 Thousand USD | -38.31% |
| 2006 FY | 2.51 Million USD | 281.57% |
| 2006 Q4 | 845.22 Thousand USD | 113.7% |
| 2006 Q3 | 395.51 Thousand USD | -43.54% |
| 2006 Q2 | 700.54 Thousand USD | 22.13% |
| 2006 Q1 | 573.59 Thousand USD | 40.58% |
| 2005 Q3 | -148.53 Thousand USD | -147.27% |
| 2005 Q4 | 408.03 Thousand USD | 374.71% |
| 2005 Q2 | 314.18 Thousand USD | 267.89% |
| 2005 Q1 | 85.4 Thousand USD | -79.2% |
| 2005 FY | 659.09 Thousand USD | -24.35% |
| 2004 Q4 | 410.53 Thousand USD | 115.53% |
| 2004 FY | 871.26 Thousand USD | 157.48% |
| 2004 Q2 | 216.29 Thousand USD | 300.82% |
| 2004 Q1 | 53.96 Thousand USD | 104.94% |
| 2004 Q3 | 190.47 Thousand USD | -11.94% |
| 2003 Q1 | -368.32 Thousand USD | -8323.38% |
| 2003 FY | -1.51 Million USD | -548.32% |
| 2003 Q4 | -1.09 Million USD | -2746.55% |
| 2003 Q3 | 41.3 Thousand USD | 143.22% |
| 2003 Q2 | -95.57 Thousand USD | 74.05% |
| 2002 Q1 | -315.64 Thousand USD | 78.44% |
| 2002 Q4 | 4479.00 USD | 17.25% |
| 2002 FY | -233.79 Thousand USD | 92.32% |
| 2002 Q3 | 3820.00 USD | -94.81% |
| 2002 Q2 | 73.54 Thousand USD | 123.3% |
| 2001 Q3 | -942.78 Thousand USD | -250.88% |
| 2001 FY | -3.04 Million USD | -381.51% |
| 2001 Q1 | -368.28 Thousand USD | -203.65% |
| 2001 Q2 | -268.69 Thousand USD | 27.04% |
| 2001 Q4 | -1.46 Million USD | -55.25% |
| 2000 Q4 | 355.3 Thousand USD | 61.4% |
| 2000 Q3 | 220.13 Thousand USD | -23.5% |
| 2000 Q2 | 287.77 Thousand USD | 32.05% |
| 2000 Q1 | 217.92 Thousand USD | -68.87% |
| 2000 FY | 1.08 Million USD | -36.41% |
| 1999 Q3 | 300 Thousand USD | -25.0% |
| 1999 Q2 | 400 Thousand USD | 33.33% |
| 1999 Q1 | 300 Thousand USD | -40.0% |
| 1999 FY | 1.7 Million USD | 6.25% |
| 1999 Q4 | 700 Thousand USD | 133.33% |
| 1998 Q1 | 200 Thousand USD | -50.0% |
| 1998 Q2 | 400 Thousand USD | 100.0% |
| 1998 Q3 | 500 Thousand USD | 25.0% |
| 1998 Q4 | 500 Thousand USD | 0.0% |
| 1998 FY | 1.6 Million USD | 23.08% |
| 1997 FY | 1.3 Million USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | 50.0% |
| 1997 Q3 | 400 Thousand USD | 33.33% |
| 1997 Q1 | 200 Thousand USD | -66.67% |
| 1997 Q4 | 400 Thousand USD | 0.0% |
| 1996 Q2 | 200 Thousand USD | 100.0% |
| 1996 FY | 1.3 Million USD | 44.44% |
| 1996 Q3 | 300 Thousand USD | 50.0% |
| 1996 Q4 | 600 Thousand USD | 100.0% |
| 1996 Q1 | 100 Thousand USD | -83.33% |
| 1995 Q3 | 200 Thousand USD | 100.0% |
| 1995 Q4 | 600 Thousand USD | 200.0% |
| 1995 Q1 | - USD | 100.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 FY | 900 Thousand USD | 136.0% |
| 1994 Q3 | -300 Thousand USD | 25.0% |
| 1994 Q1 | -500 Thousand USD | -350.0% |
| 1994 Q2 | -400 Thousand USD | 20.0% |
| 1994 FY | -2.5 Million USD | -1150.0% |
| 1994 Q4 | -1.3 Million USD | -333.33% |
| 1993 Q1 | -200 Thousand USD | 0.0% |
| 1993 Q2 | -100 Thousand USD | 50.0% |
| 1993 Q3 | -100 Thousand USD | 0.0% |
| 1993 Q4 | 200 Thousand USD | 300.0% |
| 1993 FY | -200 Thousand USD | -200.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 FY | 200 Thousand USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q4 | - USD | -100.0% |
| 1991 FY | 200 Thousand USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 172.907% |
| BrainsWay Ltd. | -4.19 Million USD | 1170.384% |
| Cerus Corporation | -37.48 Million USD | 219.832% |
| Envoy Medical, Inc. | -29.9 Million USD | 250.207% |
| electroCore, Inc. | -18.83 Million USD | 338.526% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 607.616% |
| IceCure Medical Ltd | -14.65 Million USD | 406.607% |
| Inogen, Inc. | -102.44 Million USD | 143.85% |
| OrthoPediatrics Corp. | -20.97 Million USD | 314.189% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 185.3% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 426.834% |
| MaxCyte, Inc. | -37.92 Million USD | 218.461% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 478.802% |
| Nexalin Technology, Inc. | -4.64 Million USD | 1066.376% |
| Orthofix Medical Inc. | -151.39 Million USD | 129.673% |
| PAVmed Inc | -64.17 Million USD | 170.002% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 185.623% |
| RxSight, Inc. | -48.6 Million USD | 192.421% |
| Sight Sciences, Inc. | -55.54 Million USD | 180.876% |
| SI-BONE, Inc. | -43.33 Million USD | 203.664% |
| TELA Bio, Inc. | -46.66 Million USD | 196.271% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 190.706% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 430.737% |
| Acutus Medical, Inc. | -81.66 Million USD | 155.011% |
| Talis Biomedical Corporation | -62 Million USD | 172.45% |
| Spectral AI, Inc. | -20.85 Million USD | 315.422% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 173.917% |
| CVRx, Inc. | -41.19 Million USD | 209.041% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -6917.226% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 510.067% |
| Bioventus Inc. | -156.23 Million USD | 128.755% |
| Venus Concept Inc. | -37.25 Million USD | 220.601% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 176.093% |
| LivaNova PLC | 17.54 Million USD | -156.036% |
| 908 Devices Inc. | -36.39 Million USD | 223.421% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 124.07% |
| Nemaura Medical Inc. | -14.14 Million USD | 417.625% |
| NeuroPace, Inc. | -32.95 Million USD | 236.315% |
| LENSAR, Inc. | -14.38 Million USD | 412.341% |
| Apyx Medical Corporation | -18.71 Million USD | 340.068% |
| Cutera, Inc. | -162.83 Million USD | 127.589% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 514.811% |
| BioSig Technologies, Inc. | -29.04 Million USD | 254.692% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 154.343% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 303.377% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 33.683% |
| Axonics, Inc. | -6.08 Million USD | 837.911% |
| Outset Medical, Inc. | -172.79 Million USD | 125.998% |
| IRIDEX Corporation | -9.57 Million USD | 569.425% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 142.422% |
| IRadimed Corporation | 17.19 Million USD | -161.296% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 644.93% |
| INVO Bioscience, Inc. | -8.03 Million USD | 659.131% |
| Telesis Bio, Inc. | -47.72 Million USD | 194.133% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -338.582% |
| Varex Imaging Corporation | -47.7 Million USD | 194.18% |
| Quipt Home Medical Corp. | -2.78 Million USD | 1713.649% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 498.051% |
| Pulmonx Corporation | -60.84 Million USD | 173.836% |
| Dynatronics Corporation | -2.69 Million USD | 1765.259% |
| Modular Medical, Inc. | -17.47 Million USD | 357.149% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 494.52% |
| Semler Scientific, Inc. | 20.58 Million USD | -118.258% |
| InMode Ltd. | 197.91 Million USD | 77.302% |
| Bruker Corporation | 427.2 Million USD | 89.484% |
| Cytosorbents Corporation | -28.5 Million USD | 257.587% |
| DexCom, Inc. | 541.5 Million USD | 91.704% |
| Align Technology, Inc. | 445.05 Million USD | 89.906% |
| Viveve Medical, Inc. | -22.02 Million USD | 303.95% |
| ZimVie Inc. | -393.28 Million USD | 111.423% |
| Movano Inc. | -29.28 Million USD | 253.413% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 469.806% |
| Nexalin Technology, Inc. | -4.64 Million USD | 1066.376% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -6917.226% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 120.18% |
| Profound Medical Corp. | -28.56 Million USD | 257.247% |
| Insulet Corporation | 206.3 Million USD | 78.224% |
| enVVeno Medical Corporation | -23.51 Million USD | 291.036% |
| Surmodics, Inc. | -11.54 Million USD | 489.222% |
| iCAD, Inc. | -4.84 Million USD | 1026.841% |
| Nuwellis, Inc. | -20.2 Million USD | 322.297% |
| Biotricity, Inc. | -14.09 Million USD | 418.739% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 136.403% |
| Aethlon Medical, Inc. | -12.2 Million USD | 467.983% |
| InspireMD, Inc. | -19.91 Million USD | 325.567% |
| PAVmed Inc. | -64.17 Million USD | 170.002% |
| BIOLASE, Inc. | -20.63 Million USD | 317.739% |
| Beyond Air, Inc. | -60.24 Million USD | 174.573% |
| FONAR Corporation | 10.56 Million USD | -325.119% |
| AxoGen, Inc. | -21.71 Million USD | 306.871% |
| Vivani Medical, Inc. | -25.65 Million USD | 275.129% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | -57.545% |
| Inari Medical, Inc. | -1.63 Million USD | 2845.966% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 975.314% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 780.13% |
| Tenon Medical, Inc. | -15.58 Million USD | 388.326% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 391.223% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 227.145% |
| AdaptHealth Corp. | -678.89 Million USD | 106.617% |
| Sintx Technologies, Inc. | -8.25 Million USD | 643.94% |
| NanoVibronix, Inc. | -3.71 Million USD | 1310.563% |
| Quanterix Corporation | -32.33 Million USD | 238.937% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 498.051% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -9162.68% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 114.646% |
| TransMedics Group, Inc. | -25.02 Million USD | 279.495% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 302.973% |
| NeuroMetrix, Inc. | -6.52 Million USD | 788.017% |
| Hyperfine, Inc. | -44.23 Million USD | 201.551% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 157.227% |
| Biomerica, Inc. | -5.97 Million USD | 851.489% |
| Bone Biologics Corporation | -8.94 Million USD | 602.015% |
| AVITA Medical, Inc. | -39.16 Million USD | 214.695% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 551.321% |
| Silk Road Medical, Inc | -55.74 Million USD | 180.591% |